Day: March 2, 2026

NPR News: 03-02-2026 5AM EST To manage podcast ad preferences, review the links below: See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. Learn more about sponsor message choices: podcastchoices.com/adchoices NPR Privacy Policy

India’s Godavari Biorefineries to start grain-based distillery in June quarter  reut.rs/4raI3hV  reut.rs/4raI3hV

— Reuters (@Reuters) Mar 2, 2026

UK mortgage approvals dip in January, consumer borrowing rises  reut.rs/4aLfumh  reut.rs/4aLfumh

— Reuters (@Reuters) Mar 2, 2026

The Middle East faces a major geopolitical shift following a joint U.S. and Israeli operation in Iran that resulted in the death of Supreme Leader Ayatollah Ali Khamenei and several top commanders. President Trump ordered the strike with the goal of “giving the country back to the Iranian people,” sparking debate in Washington over executive authority and the War Powers Act. Texas Republican Congressman Pat Fallon, a member of the Armed Services and Intelligence Committees, joins the Rundown to discuss the strategic implications of the attack, and the risk of retaliation at home. With 30 million Americans living with a rare disease, is the traditional “blockbuster” drug model failing the approximately one in 11 people who need specialized care? Judy Stecker, founder of Wheeler’s Warriors and former HHS official, joins us to discuss a historic shift at the FDA. From the groundbreaking use of genome editing to treat metabolic diseases to the emotional journey of her son Wheeler, Stecker explains how she believes the science of “genetic patches” has finally outpaced our regulatory system. Plus, commentary by Senior Fellow at the Lexington Institute, Dr. Rebecca Grant.
Learn more about your ad choices. Visit podcastchoices.com/adchoices

Breakingviews – Banks’ capital steroid use warrants extra scrutiny  reut.rs/4r69clZ  reut.rs/4r69clZ

— Reuters (@Reuters) Mar 2, 2026